Omega Fund Management, LLC Jounce Therapeutics, Inc. Transaction History

Omega Fund Management, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 17, 2021	SELL	$6.73 - $13.87 $400,111 - $824,599	-59,452 Reduced 17.75%	275,513 $2.83 Million
Q3 2020 Nov 16, 2020	SELL	$4.58 - $10.95 $893,100 - $2.14 Million	-195,000 Reduced 36.79%	334,965 $2.73 Million
Q1 2018 May 04, 2018	SELL	$13.4 - $28.4 $665,779 - $1.41 Million	-49,685 Reduced 8.57%	529,965 $11.8 Million
Q3 2017 Nov 03, 2017	BUY	$11.17 - $16.99 $6.47 Million - $9.85 Million	579,650	579,650 $9.03 Million

720K

Ticker JNCE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 51,694,200
Description
Jounce Therapeutics, Inc., a clinical-stage immunotherapy company, develops therapies for the treatment of cancer. The company develops vopratelimab, a clinical-stage monoclonal antibody, which is in Phase II clinical trial that binds to and activates the Inducible T cell CO-Stimulator, a protein on the surface of T cells found in various solid ...

Get notified when there are updates to the investment portfolio of Omega Fund Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Omega Fund Management, LLC with notifications on news.